Nanoscale Metal‐Organic Framework‐Based Self‐Monitoring Oxygen Economizer and ROS Amplifier for Enhanced Radiotherapy‐Radiodynamic Therapy
Advanced Science · 2025-09 · 12 (35)
DOI: 10.1002/advs.202503582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.06.2025. Verfasst von Shiye Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Metal-Organic Frameworks, Oxygen, Radiotherapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hygiene Specific Subjects of Jilin Province.
Abstract (Originalsprache)
Radiotherapy‐radiodynamic therapy (RT‐RDT) has emerged as a promising approach due to its remarkable anticancer efficacy. However, hypoxic tumor microenvironment and insufficient energy deposition severely reduce the radiotherapy outcomes. Herein, lonidamine (LND)‐loaded Fe(III) metal‐Pt(II) porphyrin framework (FPTM‐LP) is designed for radiosensitization through hypoxia alleviation and reactive oxygen species (ROS) amplification. Specifically, the high‐Z element Pt effectively absorbs X‐ray photons to generate •OH for RT while transferring X‐ray energy to porphyrin (TCPP), which stimulates the generation of 1 O 2 for RDT. Moreover, by the inhibition of oxidative phosphorylation, the weak acidity and glutathione (GSH)‐responsive release of LND achieves O 2 economization, which promotes the generation of ROS and stabilizes DNA damage. Intriguingly, Pt(II)TCPP exhibits the capability of O 2 concentration‐dependent near infrared luminescence imaging‐guided RT‐RDT. Moreover, the decomposition of FPTM‐LP under high concentration of GSH generates large amounts of Fe 2+ , leading to the augmented production of •OH via Fenton reactions. In brief, this work presents a radiosensitizer with a unique and efficient mechanism of self‐monitoring hypoxia alleviation and increasing ROS levels for enhanced cancer RT‐RDT. The radiosensitization potency of FPTM‐LP is confirmed in tumor‐bearing mice in vivo, proclaiming a new strategy for enhancing therapeutic efficacy and minimizing side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.
- Department of Radiotherapy -1 and Department of Radiotherapy -4, Jilin Province Cancer Hospital, Changchun, 130000, China.
ORCID-Profile: Shi Gao
Förderung
- National Natural Science Foundation of China
- Hygiene Specific Subjects of Jilin Province
Zitieren
APA
Du, S., Wen, Q., Han, T., Ren, J., Wang, M., Dai, Y., Ge, X., Li, L., Liu, J., & Gao, S. (2025). Nanoscale Metal‐Organic Framework‐Based Self‐Monitoring Oxygen Economizer and ROS Amplifier for Enhanced Radiotherapy‐Radiodynamic Therapy. Advanced Science, 12(35). https://doi.org/10.1002/advs.202503582
Vancouver
Du S, Wen Q, Han T, Ren J, Wang M, Dai Y, et al. Nanoscale Metal‐Organic Framework‐Based Self‐Monitoring Oxygen Economizer and ROS Amplifier for Enhanced Radiotherapy‐Radiodynamic Therapy. Advanced Science. 2025;12(35). doi:10.1002/advs.202503582
BibTeX
@article{Du2025,
author = {Du, Shiye and Wen, Qiang and Han, Ting and Ren, Jiongyu and Wang, Mingyu and Dai, Yunpeng and Ge, Xiaoguang and Li, Lu and Liu, Junzhi and Gao, Shi},
title = {Nanoscale Metal‐Organic Framework‐Based Self‐Monitoring Oxygen Economizer and ROS Amplifier for Enhanced Radiotherapy‐Radiodynamic Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {35},
doi = {10.1002/advs.202503582}
}
EUVIMED